These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29630902)

  • 41. Progesterone for Traumatic Brain Injury: A Meta-Analysis Review of Randomized Controlled Trials.
    Lu XY; Sun H; Li QY; Lu PS
    World Neurosurg; 2016 Jun; 90():199-210. PubMed ID: 26960278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repositioning drugs for traumatic brain injury - N-acetyl cysteine and Phenserine.
    Hoffer BJ; Pick CG; Hoffer ME; Becker RE; Chiang YH; Greig NH
    J Biomed Sci; 2017 Sep; 24(1):71. PubMed ID: 28886718
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of individual clinical outcomes on trial participants' perspectives on enrollment in emergency research without consent.
    Whitesides LW; Baren JM; Biros MH; Fleischman RJ; Govindarajan PR; Jones EB; Pancioli AM; Pentz RD; Scicluna VM; Wright DW; Dickert NW
    Clin Trials; 2017 Apr; 14(2):180-186. PubMed ID: 28359192
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Progesterone's role in neuroprotection, a review of the evidence.
    Deutsch ER; Espinoza TR; Atif F; Woodall E; Kaylor J; Wright DW
    Brain Res; 2013 Sep; 1530():82-105. PubMed ID: 23872219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Salsalate treatment following traumatic brain injury reduces inflammation and promotes a neuroprotective and neurogenic transcriptional response with concomitant functional recovery.
    Lagraoui M; Sukumar G; Latoche JR; Maynard SK; Dalgard CL; Schaefer BC
    Brain Behav Immun; 2017 Mar; 61():96-109. PubMed ID: 27939247
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of Female Sex Steroids Administration on Pathophysiologic Mechanisms in Traumatic Brain Injury.
    Khaksari M; Soltani Z; Shahrokhi N
    Transl Stroke Res; 2018 Aug; 9(4):393-416. PubMed ID: 29151229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug repurposing for immune modulation in acute ischemic stroke.
    Amantea D; Bagetta G
    Curr Opin Pharmacol; 2016 Feb; 26():124-30. PubMed ID: 26657075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progesterone Sharpens Temporal Response Profiles of Sensory Cortical Neurons in Animals Exposed to Traumatic Brain Injury.
    Allitt BJ; Johnstone VPA; Richards KL; Yan EB; Rajan R
    Cell Transplant; 2017 Jul; 26(7):1202-1223. PubMed ID: 28933224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury.
    Chakrabarti M; Das A; Samantaray S; Smith JA; Banik NL; Haque A; Ray SK
    Rev Neurosci; 2016 Apr; 27(3):271-81. PubMed ID: 26461840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug repurposing for drug development in stroke.
    Fagan SC
    Pharmacotherapy; 2010 Jul; 30(7 Pt 2):51S-4S. PubMed ID: 20575622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug repurposing in rare diseases: Myths and reality.
    Fetro C; Scherman D
    Therapie; 2020 Apr; 75(2):157-160. PubMed ID: 32241561
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progesterone for the treatment of experimental brain injury; a systematic review.
    Gibson CL; Gray LJ; Bath PM; Murphy SP
    Brain; 2008 Feb; 131(Pt 2):318-28. PubMed ID: 17715141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progesterone and its metabolites as therapeutic targets in psychiatric disorders.
    Bristot G; Ascoli B; Gubert C; Panizzutti B; Kapczinski F; Rosa AR
    Expert Opin Ther Targets; 2014 Jun; 18(6):679-90. PubMed ID: 24654651
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Scaffold Repurposing of Old Drugs Towards New Cancer Drug Discovery.
    Chen H; Wu J; Gao Y; Chen H; Zhou J
    Curr Top Med Chem; 2016; 16(19):2107-14. PubMed ID: 26881709
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of Glycogen Synthase Kinase-3: An Emerging Target in the Treatment of Traumatic Brain Injury.
    Shim SS; Stutzmann GE
    J Neurotrauma; 2016 Dec; 33(23):2065-2076. PubMed ID: 26979735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overcoming cancer therapeutic bottleneck by drug repurposing.
    Zhang Z; Zhou L; Xie N; Nice EC; Zhang T; Cui Y; Huang C
    Signal Transduct Target Ther; 2020 Jul; 5(1):113. PubMed ID: 32616710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacologic Neuroprotection for Functional Outcomes After Traumatic Brain Injury: A Systematic Review of the Clinical Literature.
    Gruenbaum SE; Zlotnik A; Gruenbaum BF; Hersey D; Bilotta F
    CNS Drugs; 2016 Sep; 30(9):791-806. PubMed ID: 27339615
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feasibility of progesterone treatment for ischaemic stroke.
    Gibson CL; Bath PM
    J Cereb Blood Flow Metab; 2016 Mar; 36(3):487-91. PubMed ID: 26661235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions.
    Polamreddy P; Gattu N
    Drug Discov Today; 2019 Mar; 24(3):789-795. PubMed ID: 30513339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Update on pharmacotherapy for stroke and traumatic brain injury recovery during rehabilitation.
    Liepert J
    Curr Opin Neurol; 2016 Dec; 29(6):700-705. PubMed ID: 27748687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.